Literature DB >> 8951185

Drug and Therapeutics Committees in Australia: expected and actual performance.

L M Weekes1, C Brooks.   

Abstract

1. This study describes stakeholders' opinions on Drug and Therapeutics Committees (DTCs) and measures the composition, activities and perceived effectiveness of DTCs in Australia. 2. Focus groups explored the opinions of clinicians, consumers and administrators on the goals, objectives and strategies of DTCs. 3. A national survey was sent to 306 hospitals to collect data on the composition, committee processes, goals, objectives, educational activities, policies and decision making of DTCs. 4. Stakeholders believed the DTC should optimise therapeutic health outcomes for patients and economic outcomes for the hospital. Important objectives were availability of safe, efficacious and cost-effective medicines, affordability of medicines and quality use of medicines. 5. The national survey of DTCs found that over 92% of respondents had a DTC in their hospital. Composition was generally representational and most commonly included members from the disciplines of internal medicine, pharmacy and nursing. More than half the DTCs had executive authority although only 21% had an appeals mechanism. 6. The most commonly cited issues for DTCs in 1994-95 were quality drug use, drug policies and spending on high cost drugs. 7. While access to clinical pharmacologists and specialist drug utilisation evaluation (DUE) pharmacists was poor, 71% of DTCs had access to DUE data of some sort. Guidelines (61%), prescribing restrictions (60%) and pharmacist monitoring (63%) were the most commonly used strategies to implement DTC policies and decisions. Audit-feedback activities (61%) and drug bulletins (56%) were the most commonly used interventions. 8. Available information for formulary decision making varied with small rural hospitals having access to significantly less information. The most commonly used information was availability of a therapeutic alternative (87%), efficacy (83%), cost (80%) and estimated usage (78%). 9. On average DTCs reported an ability to implement 75% of decisions (range 0-95%) with teaching hospitals perceived to perform better than other hospital types. 10. This study reveals a high level of expectation for DTC activities and achievements. In Australia DTCs were involved in policy, education and management initiatives to promote best practice in therapeutics. Few committees appeared to have adequate resources to extend services to their wider community.

Entities:  

Mesh:

Year:  1996        PMID: 8951185     DOI: 10.1111/j.1365-2125.1996.tb00048.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Medication errors: hospital pharmacist perspective.

Authors:  Henk-Jan Guchelaar; Hadewig B B Colen; Mathijs D Kalmeijer; Patrick T W Hudson; Irene M Teepe-Twiss
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Improving the performance of Drug and Therapeutics Committees in hospitals--a quasi-experimental study in Laos.

Authors:  Chu Vang; Goran Tomson; Sengchan Kounnavong; Thanakhanh Southammavong; Amphayvanh Phanyanouvong; Rolf Johansson; Bo Eriksson; Rolf Wahlstrom
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

4.  Health professionals: how do they assess new medicines?

Authors:  Rebecca Cheng; Kirsty Cook; Sarah Dowman; Rebecca Lawn; Jemma Leary; Taryn Quinn; Kim Schroder; Nicola Smith; June Tordoff
Journal:  Pharm World Sci       Date:  2005-06

Review 5.  The judicious use of antibiotics--an investment towards optimized health care.

Authors:  Aditya H Gaur; B Keith English
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 1.967

6.  Prioritising drug and therapeutics committee (DTC) decisions: a national survey.

Authors:  Ee Lyn Tan; Richard O Day; Jo-anne E Brien
Journal:  Pharm World Sci       Date:  2006-12-23

7.  Hospital-based adverse drug reaction bulletin : an Indian experience.

Authors:  Jimmy Jose; Padma G M Rao; Beena Jimmy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

8.  Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.

Authors:  P Ravi Shankar; Baburam Humagain; R M Piryani; Nisha Jha; Bidur Osti
Journal:  Pharm World Sci       Date:  2008-12-05

9.  Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes.

Authors:  Adeline Gallini; Blandine Juillard-Condat; Marie-Claude Saux; Florence Taboulet
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

10.  Hospital drug and therapeutics committees in Australia: is there a role for economic evaluation at the institutional level?

Authors:  Gisselle Gallego
Journal:  Int J Clin Pharm       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.